SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Exor N.V. (EXXRF) , 前瞻盈利收益率 7.46%. PEG 0.70 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
- 前瞻市盈率 13.4
- PEG 比率 0.70 — 低于1.0表明股票相对于其盈利增长率被低估(Peter Lynch 标准)。
SharesGrow 综合评分: 66/100 其中 1/7 项标准通过。
SharesGrow 7-Criteria Score
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
估值概览 — EXXRF
估值倍数
P/E (TTM)0.0
前瞻 P/E13.4
PEG 比率0.70
前瞻 PEG0.70
P/B 比率0.00
P/S 比率0.00
EV/EBITDA0.0
每股数据
EPS (TTM)$-18.48
前瞻 EPS(预估)$6.19
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
Forward Earnings Yield7.46%
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS(稀释) |
营收 |
净利润 |
净利润率 |
| 2016 |
$2.47 |
$140.1B |
$589M |
0.4% |
| 2017 |
$5.87 |
$143.44B |
$1.39B |
1% |
| 2018 |
$5.73 |
$143.3B |
$1.35B |
0.9% |
| 2019 |
$21.53 |
$143.76B |
$3.05B |
2.1% |
| 2020 |
$0.00 |
$119.52B |
$-30M |
-0% |
| 2021 |
$7.79 |
$33.62B |
$1.72B |
5.1% |
| 2022 |
$18.10 |
$41.84B |
$4.23B |
10.1% |
| 2023 |
$18.42 |
$44.74B |
$4.19B |
9.4% |
| 2024 |
$67.00 |
$15.4B |
$14.67B |
95.3% |
| 2025 |
$-18.48 |
$-3.59B |
$-3.79B |
- |